EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Catecholaminergic Modulation of Metacontrol Is Reflected by Changes in Aperiodic EEG Activity

Yang Gao, Veit Roessner, Ann-Kathrin Stock, Moritz Mückschel, Lorenza Colzato, Bernhard Hommel iD, Christian Beste

International Journal of Neuropsychopharmacology · 01.08.2024 · 27 (8)

DOI: 10.1093/ijnp/pyae033 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Neuropsychopharmacology, online erschienen am 03.08.2024. Verfasst von Yang Gao und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Psychology, Shandong Normal University, Jinan, China. Hauptthemen laut MEDLINE: Methylphenidate, Electroencephalography. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background “Metacontrol” describes the ability to maintain an optimal balance between cognitive control styles that are either more persistent or more flexible. Recent studies have shown a link between metacontrol and aperiodic EEG patterns. The present study aimed to gain more insight into the neurobiological underpinnings of metacontrol by using methylphenidate (MPH), a compound known to increase postsynaptic catecholamine levels and modulate cortical noise.

Methods

In a double-blind, randomized, placebo-controlled study design, we investigated the effect of MPH (0.5 mg/kg) on aperiodic EEG activity during a flanker task in a sample of n = 25 neurotypical adults. To quantify cortical noise, we employed the fitting oscillations and one over f algorithm.

Results

Compared with placebo, MPH increased the aperiodic exponent, suggesting that it reduces cortical noise in 2 ways. First, it did so in a state-like fashion, as the main effect of the drug was visible and significant in both pre-trial and within-trial periods. Second, the electrode-specific analyses showed that the drug also affects specific processes by dampening the downregulation of noise in conditions requiring more control.

Conclusions

Our findings suggest that the aperiodic exponent provides a neural marker of metacontrol states and changes therein. Further, we propose that the effectiveness of medications targeting catecholaminergic signaling can be evaluated by studying changes of cortical noise, fostering the idea of using the quantification of cortical noise as an indicator in pharmacological treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethylphenidateElectroencephalographyHumansDouble-Blind MethodMaleAdultFemaleYoung AdultCentral Nervous System StimulantsCatecholaminesBrain Waves

Stichwörter der Autor:innen

Aperiodic EEG activitycatecholaminesmetacontrolmethylphenidate

Substanzen

MethylphenidateCentral Nervous System StimulantsCatecholamines

Autor:innen und Institutionen

  • School of Psychology, Shandong Normal University, Jinan, China.
  • Cognitive Neurophysiology, Department of Child and Adolescent Psychiatry, Faculty of Medicine, TU Dresden, Dresden, Germany.

ORCID-Profile: Bernhard Hommel

Zitieren

APA

Gao, Y., Roessner, V., Stock, A. K., Mückschel, M., Colzato, L., Hommel, B., & Beste, C. (2024). Catecholaminergic Modulation of Metacontrol Is Reflected by Changes in Aperiodic EEG Activity. International Journal of Neuropsychopharmacology, 27(8). https://doi.org/10.1093/ijnp/pyae033

Vancouver

Gao Y, Roessner V, Stock AK, Mückschel M, Colzato L, Hommel B, et al. Catecholaminergic Modulation of Metacontrol Is Reflected by Changes in Aperiodic EEG Activity. International Journal of Neuropsychopharmacology. 2024;27(8). doi:10.1093/ijnp/pyae033

BibTeX
@article{Gao2024,
  author = {Gao, Yang and Roessner, Veit and Stock, Ann-Kathrin and Mückschel, Moritz and Colzato, Lorenza and Hommel, Bernhard and Beste, Christian},
  title = {Catecholaminergic Modulation of Metacontrol Is Reflected by Changes in Aperiodic EEG Activity},
  journal = {International Journal of Neuropsychopharmacology},
  year = {2024},
  volume = {27},
  number = {8},
  doi = {10.1093/ijnp/pyae033}
}
Kostenlos starten →